Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc. (IONS)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
54. 39
-0.26
-0.4758%
$
9.04B Market Cap
- P/E Ratio
- Div Yield
2.57M Volume
-3.43 Eps
$ 54.65
Previous Close
Add Transaction
Day Range
53.76 54.69
Year Range
40.03 86.74
Want to track IONS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ionis Pharmaceuticals, Inc. (IONS) Statistics

Valuation metrics

Market Cap 9.04B
Enterprise value 10.86B
Trailing P/E (ttm) -27.33
Forward P/E -121.81
PEG ratio 5.1
Price/Sales (ttm) 8.5
Price/Book (mrq) 18.25
Enterprise Value/Revenue 10.26
Enterprise Value/EBITDA 2.37

Overview

Shares outstanding 163.3M
Float 163.91M
Shares short 14.33M
% Held by insiders 0.01%
% Held by institutions 1.06%
Average volume (10 days) 5.14M
Average volume (90 days) 2.34M

Price summary

52-Week low 40.03
52-Week high 86.74
Beta 0.4
50-Day moving average 70.54
200-Day moving average 76.19

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.31%
Operating margin -0.33%

Operational effectiveness

Return on assets -0.09%
Return on equity -0.59%

Income Statement

Revenue (ttm) 943.71M
Revenue per share (ttm) 6.42
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 12.18M
EBITDA -369.24M
Net income to common (ttm) -381.39M
Diluted EPS (ttm) -1.98
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 2.68B
Total cash per share (mrq) 11.64
Total debt (mrq) 2.62B
Total Debt/Equity (mrq) 4.15
Current ratio (mrq) 4.1%
Book value per share (mrq) 2.98

Cash Flow

Cash flow statement -268.58M
Levered free cash flow (LFCF) -154.72M